These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14530622)

  • 1. Assessment of driving performance in patients with relapsing-remitting multiple sclerosis by a driving simulator.
    Kotterba S; Orth M; Eren E; Fangerau T; Sindern E
    Eur Neurol; 2003; 50(3):160-4. PubMed ID: 14530622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of driving skills in persons with relapsing-remitting multiple sclerosis: a pilot study.
    Akinwuntan AE; Devos H; Baker K; Phillips K; Kumar V; Smith S; Williams MJ
    Arch Phys Med Rehabil; 2014 Mar; 95(3):531-7. PubMed ID: 24161271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of the Multiple Sclerosis Functional Composite in Debrecen].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
    Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis.
    Waldman AT; Chahin S; Lavery AM; Liu G; Banwell BL; Liu GT; Balcer LJ
    Mult Scler Relat Disord; 2016 Nov; 10():73-78. PubMed ID: 27919503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.
    Jongen PJ; Sindic C; Carton H; Zwanikken C; Lemmens W; Borm G;
    J Neurol; 2010 Apr; 257(4):584-9. PubMed ID: 19921303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].
    Kotterba S; Eren E; Fangerau T; Malin JP; Sindern E
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):590-4. PubMed ID: 14608510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Bellmann-Strobl J; Wuerfel J; Aktas O; Dörr J; Wernecke KD; Zipp F; Paul F
    Neurology; 2009 Nov; 73(20):1624-7. PubMed ID: 19917984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
    Vázquez-Marrufo M; Galvao-Carmona A; Caballero-Díaz R; Borges M; Paramo MD; Benítez-Lugo ML; Ruiz-Peña JL; Izquierdo G
    PLoS One; 2019; 14(7):e0219594. PubMed ID: 31306457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up study of relapsing-remitting MS patients' cognitive performances: Paced Auditory Serial Addition Test's susceptibility to change.
    Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
    J Int Neuropsychol Soc; 2007 Sep; 13(5):791-8. PubMed ID: 17697410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PASAT performance among patients with multiple sclerosis: analyses of responding patterns using different scoring methods.
    Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
    Mult Scler; 2006 Oct; 12(5):586-93. PubMed ID: 17086904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational validity of PASAT and the effect of fatigue and mood in patients with relapsing remitting MS: A functional MRI study.
    Iancheva D; Trenova AG; Terziyski K; Kandilarova S; Mantarova S
    J Eval Clin Pract; 2018 Aug; 24(4):832-838. PubMed ID: 29611255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition test.
    Ozakbas S; Ormeci B; Akdede BB; Alptekin K; Idiman E
    Mult Scler; 2004 Dec; 10(6):686-9. PubMed ID: 15584495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.